Synthesis and in vitro stability of macromolecular prodrugs of norfloxacin
- 8 September 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 47 (3) , 283-291
- https://doi.org/10.1016/s0168-3659(97)01655-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Biodegradable Microspheres. 17. Lysosomal Degradation of Primaquine–Peptide Spacer ArmsJournal of Pharmaceutical Sciences, 1995
- Specific targeting of the antiviral drug 5-Iodo 2′-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysineJournal of Hepatology, 1994
- Tissue-Directed Antibiotics and Intracellular Parasites: Complex Interaction of Phagocytes, Pathogens, and DrugsClinical Infectious Diseases, 1994
- Quinolone AntibacterialsDrugs, 1994
- ComparativeIn Vitroevaluation of cumulative release of the urinary antiseptics Nalidixic acid, Pipemidic acid, Cinoxacin, and norfloxacin from white beeswax MicrospheresDrug Development and Industrial Pharmacy, 1994
- Macromolecular Drug Conjugates II. Metronidazole-Dextran ProdrugsJournal of Bioactive and Compatible Polymers, 1993
- Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher diseaseThe Journal of Pediatrics, 1992
- Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymersJournal of Controlled Release, 1991
- Action of polymeric prodrugs based on N-(2-hydroxypropyl)meth- acrylamide copolymers. I. Suppression of the antibody response and proliferation of mouse splenocytes in vitroJournal of Controlled Release, 1989
- Soluble Synthetic Polymers for Targeting and Controlled Release of Anticancer Agents, Particularly Anthracycline AntibioticsJournal of Bioactive and Compatible Polymers, 1988